Table 1 Demographics and baseline characteristics of all dosed participants and completers in studies 1 and 2
Characteristics | Study 1 (2 tablets IR/ER HB/APAP) | Study 2 (3 tablets IR/ER HB/APAP) | ||
|---|---|---|---|---|
All dosed participants | Completers | All dosed participants | Completers | |
(N = 48) | (n = 40) | (N = 30) | (n = 21) | |
Mean (SD) age, y | 33.3 (10.1) | 33.2 (10.3) | 35.2 (10.8) | 36.1 (10.4) |
Women, n (%) | 24 (50.0) | 18 (45.0) | 15 (50.0) | 7 (33.3) |
Race, n (%) | ||||
White | 36 (75.0) | 31 (77.5) | 25 (83.3) | 18 (85.7) |
Black | 12 (25.0) | 9 (22.5) | 3 (10.0) | 1 (4.8) |
Asian | 0 | 0 | 1 (3.3) | 1 (4.8) |
American Indian or Alaskan Native | 0 | 0 | 1 (3.3) | 1 (4.8) |
Ethnicity, n (%) | ||||
Hispanic or Latino | 17 (35.4) | 15 (37.5) | 11 (36.7) | 7 (33.3) |
Not Hispanic or Latino | 31 (64.6) | 25 (62.5) | 19 (63.3) | 14 (66.7) |
Mean (SD) height, cm | 167.9 (9.3) | 168.6 (8.8) | 168.7 (9.5) | 171.1 (9.7) |
Mean (SD) weight, kg | 72.6 (12.3) | 73.6 (12.6) | 74.3 (11.0) | 76.7 (11.5) |
Mean (SD) body mass index, kg/m2 | 25.6 (3.0) | 25.8 (3.1) | 26.1 (2.8) | 26.1 (2.5) |